EPE243 | Estimating program and patient cost-savings from multi-month ARV dispensing in Vietnam's Social Health Insurance scheme: strengthening scale up decision-making | E-poster | Costing of HIV, hepatitis and STI services |
EPE244 | Use of generic ritonavir-boosted darunavir and dolutegravir for second line antiretroviral therapy is cost-effective in Zambia: a 10-year modelling analysis | E-poster | Costing of HIV, hepatitis and STI services |
EPE245 | Cost of caregiver-assisted oral HIV screening of children in Uganda and Zambia | E-poster | Costing of HIV, hepatitis and STI services |
EPE246 | Costs of pharmacy, workplace and hotspot HIV self-testing in Kenya | E-poster | Costing of HIV, hepatitis and STI services |
EPE247 | Financial cost of a PrEP program among adolescent men who have sex with men and transgender women in Brazil | E-poster | Costing of HIV, hepatitis and STI services |
EPE248 | A shift from onsite to online dissemination of new WHO treatment guidelines for HIV and TB through short interactive courses for health workers. Is it cost effective? | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
EPE249 | Affordability of integrating early childhood development into PMTCT programs | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
EPE250 | Cost'benefit analysis of investments made in Morocco since the creation of the Global Fund (2002 - 2020) for HIV control | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
EPE251 | Decentralized drug distribution of antiretroviral therapy in Eswatini: cost-saving or cost-shifting? | E-poster | Economic evaluation and affordability assessments |
EPE252 | Socio-economic impact of HIV and AIDS in Ghana: a review of the out-of-pocket expenditure of people living with HIV in Ghana | E-poster | Economic evaluation and affordability assessments |